Testing a dust mite allergy treatment with injections

This trial is testing MM09, an immunotherapy treatment given by injection, to see if it can help people with dust mite allergies and related asthma. Dust mites are a common allergen that trigger sneezing, congestion, itchy eyes, and sometimes asthma symptoms. The study will compare this medication to a placebo (a fake injection with no active ingredient) over one year to measure whether it safely reduces these symptoms.

Dust mite allergies are very common and can significantly affect quality of life, especially for people whose symptoms include asthma. Current treatments mainly manage symptoms, but this medication aims to actually train your immune system to tolerate dust mites better—potentially offering long-lasting relief.